|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 15.58 USD | +3.32% |
|
-5.63% | -14.21% |
| 09-20 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 08-19 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.32% | -5.63% | -20.47% | -19.23% | -14.21% | +19.66% | -46.22% | -99.76% | -99.88% | 809M | |
| -0.70% | -4.28% | +2.07% | +27.34% | +77.25% | +52.62% | +86.42% | +7.04% | - | 71.81B | |
| +0.45% | -0.82% | -5.23% | +8.02% | +18.36% | +38.81% | +84.19% | +233.10% | +5,488.93% | 60.06B | |
| +2.90% | +4.26% | +12.71% | +59.10% | +75.10% | +34.33% | +23.85% | -56.48% | - | 27.93B | |
| -1.73% | -4.30% | -2.45% | +10.40% | -33.56% | -18.37% | +357.94% | +340.83% | +729.48% | 25.7B | |
| -0.51% | -2.28% | -3.43% | +4.57% | +3.54% | +0.48% | -9.27% | -64.47% | - | 24.89B | |
| +0.65% | +1.67% | +7.47% | +34.83% | +14.31% | +26.47% | -7.62% | -14.97% | +105.41% | 20.92B | |
| +3.46% | +3.02% | -22.65% | +4.38% | +182.04% | +158.90% | +337.81% | +1,394.96% | +639.22% | 15.04B | |
| +0.48% | +0.86% | +7.71% | +8.05% | +33.81% | +44.56% | +168.42% | +184.29% | +377.61% | 14.46B | |
| +3.64% | +1.41% | -1.49% | +12.29% | +24.89% | -4.71% | +523.16% | - | - | 13.87B | |
| +5.88% | -4.26% | +19.37% | +14.46% | -6.29% | -22.54% | +776.47% | +239.34% | +76.05% | 12.35B | |
| -1.47% | -1.81% | -4.56% | -3.38% | -12.52% | +14.97% | +248.84% | +536.56% | +4,051.92% | 11.95B | |
| +0.94% | +10.05% | +19.35% | +21.86% | -5.04% | -24.01% | +205.70% | +150.70% | - | 10.8B | |
| +1.21% | -7.81% | -21.98% | -17.70% | -0.21% | +96.12% | +146.56% | +9.27% | +807.53% | 9.25B | |
| -0.79% | -2.89% | -8.95% | -24.78% | +3.31% | +21.80% | +122.81% | +95.42% | +633.41% | 9.2B | |
| +3.64% | -4.95% | +9.69% | +0.68% | +345.96% | +243.58% | +422.49% | -8.12% | - | 9.03B | |
| -2.71% | -3.95% | -5.26% | -1.78% | +22.87% | +63.61% | +11.20% | +120.24% | - | 8.67B | |
| +0.94% | -4.19% | -6.44% | +1.62% | +4.86% | -35.58% | +99.74% | -23.43% | - | 7.96B | |
| -1.25% | -7.88% | -6.24% | -6.03% | +158.61% | +417.85% | +591.59% | -56.33% | -49.04% | 7.56B | |
| +0.25% | +3.35% | -6.55% | -0.71% | +2.02% | +0.38% | +172.02% | +276.91% | - | 7.1B | |
| Average | +0.43% | -3.06% | -1.87% | +6.70% | +44.75% | +56.45% | +215.80% | +171.85% | +1,160.06% | 18.47B | |
| Weighted average by Cap. | +0.25% | -2.48% | -0.17% | +14.83% | +43.74% | +44.70% | +170.95% | +162.08% | +2,284.40% |
- Stock Market
- Stocks
- AVTX Stock
- Sector Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
